Literature DB >> 22425717

Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease.

Paul G Unschuld1, Suresh E Joel, Xinyang Liu, Megan Shanahan, Russell L Margolis, Kevin M Biglan, Susan S Bassett, David J Schretlen, Graham W Redgrave, Peter C M van Zijl, James J Pekar, Christopher A Ross.   

Abstract

Huntington's Disease (HD) is a neurodegenerative disease caused by a CAG triplet-repeat expansion-mutation in the Huntingtin gene. Subjects at risk for HD can be identified by genetic testing in the prodromal phase. Structural changes of basal-ganglia nuclei such as the caudate nucleus are well-replicated findings observable early in prodromal-HD subjects and may be preceded by distinct functional alterations of cortico-striatal circuits. This study aims to assess functional integrity of the motor system as a cortico-striatal circuit with particular clinical relevance in HD. Ten subjects in the prodromal phase of HD and ten matched controls were administered blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) at rest (3T). Functional connectivity was measured as synchrony of BOLD activity between the caudate nucleus and thirteen cortical brain regions (seeds). Basal-ganglia volumes were assessed as established markers of disease progression in prodromal-HD. Linear regression analysis was performed to test for a relationship between structural changes and group differences in functional connectivity. Prodromal-HD subjects showed reduced BOLD synchrony between two seeds in the premotor cortex (BA6) and the caudate nucleus. While similar effect sizes could be observed for reduced basal-ganglia volumes and differences in functional connectivity, coefficients of determination indicate a moderate relationship between functional connectivity and striatal atrophy. Our data show reduced cortico-striatal functional connectivity at rest in prodromal-HD and suggest a relation to early structural brain changes. Additional longitudinal studies are necessary to elucidate the temporal relationship between functional alterations and earliest structural brain changes in prodromal-HD.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22425717      PMCID: PMC3331724          DOI: 10.1016/j.neulet.2012.02.095

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  45 in total

1.  Declaration of Helsinki.

Authors: 
Journal:  Law Med Health Care       Date:  1991 Fall-Winter

2.  Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study.

Authors:  E H Aylward; A Rosenblatt; K Field; V Yallapragada; K Kieburtz; M McDermott; L A Raymond; E W Almqvist; M Hayden; C A Ross
Journal:  Brain Res Bull       Date:  2003-12-15       Impact factor: 4.077

3.  Functional connectivity as revealed by spatial independent component analysis of fMRI measurements during rest.

Authors:  Vincent G van de Ven; Elia Formisano; David Prvulovic; Christian H Roeder; David E J Linden
Journal:  Hum Brain Mapp       Date:  2004-07       Impact factor: 5.038

4.  Functional brain changes in presymptomatic Huntington's disease.

Authors:  Sarah A J Reading; Adam C Dziorny; Laura A Peroutka; Mathew Schreiber; Lisa M Gourley; Venu Yallapragada; Adam Rosenblatt; Russell L Margolis; James J Pekar; Godfrey D Pearlson; Elizabeth Aylward; Jason Brandt; Susan S Bassett; Christopher A Ross
Journal:  Ann Neurol       Date:  2004-06       Impact factor: 10.422

5.  Functional connectivity: the principal-component analysis of large (PET) data sets.

Authors:  K J Friston; C D Frith; P F Liddle; R S Frackowiak
Journal:  J Cereb Blood Flow Metab       Date:  1993-01       Impact factor: 6.200

6.  Rate of functional decline in Huntington's disease. Huntington Study Group.

Authors:  K Marder; H Zhao; R H Myers; M Cudkowicz; E Kayson; K Kieburtz; C Orme; J Paulsen; J B Penney; E Siemers; I Shoulson
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

7.  The measurement of abnormal movement: methods developed for Huntington's disease.

Authors:  S E Folstein; B Jensen; R J Leigh; M F Folstein
Journal:  Neurobehav Toxicol Teratol       Date:  1983 Nov-Dec

8.  Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease.

Authors:  H S Mayberg; S E Starkstein; C E Peyser; J Brandt; R F Dannals; S E Folstein
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

Review 9.  Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment.

Authors:  Helen S Mayberg
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

10.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

View more
  40 in total

Review 1.  C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity.

Authors:  Jennifer S Yokoyama; Daniel W Sirkis; Bruce L Miller
Journal:  Am J Neurodegener Dis       Date:  2014-03-28

2.  Frontal cortex BOLD signal changes in premanifest Huntington disease: a possible fMRI biomarker.

Authors:  Stefania Ferraro; Lorenzo Nanetti; Sylvie Piacentini; Maria L Mandelli; Nicola Bertolino; Francesco Ghielmetti; Francesca Epifani; Anna Nigri; Franco Taroni; Maria G Bruzzone; Stefano Di Donato; Mario Savoiardo; Caterina Mariotti; Marina Grisoli
Journal:  Neurology       Date:  2014-06-04       Impact factor: 9.910

3.  Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease.

Authors:  Fatma Gargouri; Arnaud Messé; Vincent Perlbarg; Romain Valabregue; Peter McColgan; Lydia Yahia-Cherif; Sara Fernandez-Vidal; Ahmed Ben Hamida; Habib Benali; Sarah Tabrizi; Alexandra Durr; Stéphane Lehéricy
Journal:  Hum Brain Mapp       Date:  2016-11       Impact factor: 5.038

Review 4.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

5.  Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up study.

Authors:  Omar F F Odish; Annette A van den Berg-Huysmans; Simon J A van den Bogaard; Eve M Dumas; Ellen P Hart; Serge A R B Rombouts; Jeroen van der Grond; Raymund A C Roos
Journal:  Hum Brain Mapp       Date:  2014-08-19       Impact factor: 5.038

6.  Resting-state connectivity and modulated somatomotor and default-mode networks in Huntington disease.

Authors:  Cristina Sánchez-Castañeda; Francesco de Pasquale; Chiara Falletta Caravasso; Massimo Marano; Sabrina Maffi; Simone Migliore; Umberto Sabatini; Ferdinando Squitieri
Journal:  CNS Neurosci Ther       Date:  2017-05-02       Impact factor: 5.243

7.  Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.

Authors:  Ana María Estrada-Sánchez; Courtney L Burroughs; Stephen Cavaliere; Scott J Barton; Shirley Chen; X William Yang; George V Rebec
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

Review 8.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

9.  Altered resting-state connectivity in Huntington's disease.

Authors:  Cornelius J Werner; Imis Dogan; Christian Saß; Shahram Mirzazade; Johannes Schiefer; N Jon Shah; Jörg B Schulz; Kathrin Reetz
Journal:  Hum Brain Mapp       Date:  2013-08-24       Impact factor: 5.038

10.  Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits.

Authors:  Spencer U McKinstry; Yonca B Karadeniz; Atesh K Worthington; Volodya Y Hayrapetyan; M Ilcim Ozlu; Karol Serafin-Molina; W Christopher Risher; Tuna Ustunkaya; Ioannis Dragatsis; Scott Zeitlin; Henry H Yin; Cagla Eroglu
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.